[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359538-105":59,"doc-detail-359538-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-lncrna-rp11-358l41-attenuates-breast-cancer-cell-proliferation-and-is-associated-with-cell-cycle-and-immune-related-transcriptomic-signatures","Targeting lncRNA RP11-358L4.1 attenuates breast cancer cell proliferation and is associated with cell cycle and immune-related transcriptomic signatures","","Breast cancer remains a major cause of morbidity and mortality, yet the function of the long non-coding RNA RP11-358L4.1 in progression and chemotherapy response is unclear. Expression of RP11-358L4.1 was assessed in paired tissues, and knockdown experiments in MCF-7 and BT-474 evaluated proliferation, apoptosis, migration, cell-cycle regulators, carboplatin sensitivity, and transcriptomic downstream targets. Results link RP11-358L4.1 to aggressive phenotypes, immune- and cell-cycle-associated signatures, and prognostic correlations with CXCL11 and KLF2.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-lncrna-rp11-358l41-attenuates-breast-cancer-cell-proliferation-and-is-associated-with-cell-cycle-and-immune-related-transcriptomic-signatures/359538/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-lncrna-rp11-358l41-attenuates-breast-cancer-cell-proliferation-and-is-associated-with-cell-cycle-and-immune-related-transcriptomic-signatures/359538.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question about RP11-358L4.1?","Question",{"text":112,"@type":113},"The study investigates how RP11-358L4.1 influences breast cancer progression and chemotherapeutic response, including its relationship with cell-cycle and immune-related gene signatures.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was RP11-358L4.1 function tested in breast cancer cells?",{"text":117,"@type":113},"RP11-358L4.1 expression was measured in paired breast cancer and adjacent normal tissues, and knockdown in MCF-7 and BT-474 assessed proliferation, apoptosis, migration, cell-cycle effects, and carboplatin sensitivity.",{"name":119,"@type":110,"acceptedAnswer":120},"Which downstream genes and prognostic markers were identified?",{"text":121,"@type":113},"Integrated transcriptomic analyses nominated CXCL11 and KLF2 as candidate genes associated with RP11-358L4.1-related transcriptional patterns. Higher CXCL11 related to worse distant metastasis-free survival, while higher KLF2 associated with better outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359538,1790954453,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Yangyang et al. World Journal of Surgical Oncology (2026) 24:157  \n[https://doi.org/10.1186/s12957-026-04267-w](https://doi.org/10.1186/s12957-026-04267-w)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nTargeting lncRNA RP11-358L4.1 attenuates breast cancer cell proliferation and is associated with cell cycle and immune-related transcriptomic signatures  \nZhong Yangyang1†, Lv Xiaoyu2†, He Yusong1†, Sun Kai1, Zhang Bensi2, Liu Zhenlin2, Shi Chun3, Li Yunfei1, Zhou Weixiu1, Li Tong2, Wang Siqi2 and Li Zhuang1*  \nAbstract  \nBackground Breast cancer (BC) is a leading cause of morbidity and mortality in women, with metastasis and recurrence being major determinants of poor prognosis. Long non-coding RNAs (lncRNAs) have emerged as important regulators in cancer biology, but the role of RP11-358L4 .1 in BC progression and chemotherapeutic response remains unclear.  \nMethods RP11-358L4 .1 expression was measured in 25 paired BC and adjacent normal tissues. Functional assays following RP11-358L4 .1 knockdown in MCF-7 and BT-474 cells assessed proliferation, apoptosis, migration, and carboplatin sensitivity. Expression of cell cycle regulators CDK1, CDK2, and p21 was evaluated. Transcriptomic sequencing, integrated with GEO datasets, was used to identify downstream targets, followed by gene set enrichment and immune infiltration analyses. Kaplan-Meier survival analysis determined prognostic relevance.  \nResults RP11-358L4 .1 was upregulated in breast cancer tissues and cell lines. RP11-358L4 .1 knockdown suppressed proliferation and migration, increased apoptosis, and induced G0/G1 arrest in MCF-7 and BT-474 cells. RNA-seq and integrated transcriptomic analyses nominated CXCL11 and KLF2 as candidate genes associated with RP11-358L4 .1-related transcriptional patterns, with enrichment results suggesting immune-and cell-cycle-related signatures. Immune-cell deconvolution further suggested differences in estimated immune infiltration across groups. In survival analyses, higher CXCL11 expression was associated with worse distant metastasis-free survival and showed a trend toward poorer overall survival, whereas higher KLF2 expression was associated with better outcomes.  \nConclusion RP11-358L4 .1 is associated with aggressive cellular phenotypes and platinum response in vitro. CXCL11 and KLF2 represent candidate correlates linked to RP11-358L4 .1 associated transcriptional signatures, providing testable hypotheses for future mechanistic and clinical validation.  \n†Zhong Yangyang, Lv Xiaoyu and He Yusong contributed equally to this work.  \n*Correspondence: Li Zhuang [18987206969@189.cn](18987206969@189.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nYangyang et al. World Journal of Surgical Oncology (2026) 24:157 Page 2 of 18  \nKeywords breast cancer, lncRNA RP11-358L4 . 1","cbCaivQcyVoFGiEq","https://ap.wps.com/l/cbCaivQcyVoFGiEq","pdf",6057273,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer burden and heterogeneity\n## Genomic instability and roles of lncRNAs","[{\"question\":\"What is the main research question about RP11-358L4.1?\",\"answer\":\"The study investigates how RP11-358L4.1 influences breast cancer progression and chemotherapeutic response, including its relationship with cell-cycle and immune-related gene signatures.\"},{\"question\":\"How was RP11-358L4.1 function tested in breast cancer cells?\",\"answer\":\"RP11-358L4.1 expression was measured in paired breast cancer and adjacent normal tissues, and knockdown in MCF-7 and BT-474 assessed proliferation, apoptosis, migration, cell-cycle effects, and carboplatin sensitivity.\"},{\"question\":\"Which downstream genes and prognostic markers were identified?\",\"answer\":\"Integrated transcriptomic analyses nominated CXCL11 and KLF2 as candidate genes associated with RP11-358L4.1-related transcriptional patterns. Higher CXCL11 related to worse distant metastasis-free survival, while higher KLF2 associated with better outcomes.\"}]","Targeting lncRNA RP11-358L4.1 attenuates breast cancer cell proliferation and is associated with cell cycle and immune-related transcriptomic signatures | PDF",1790137138,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2495ec9137a4c6d971c81b66e3de03dd.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14af1ae8053dcf72a519868fa2f52904.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b023b4dfe22cbbb0b6b4522655944f3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7139085c02ab25e2368b41534a1fd206.webp",980,1306]